Ovarian Diseases (Ovarian Disease)

12/01/1990 - "Thus, we conclude that our primate model of combination therapy, GnRH antagonist plus pulsatile GnRH, establishes the possibility of a new clinical treatment regimen for patients desiring relief from the sequelae of hyperandrogenemia (polycystic ovarian disease) and ovulatory dysfunction."
08/01/2005 - "The efficacy of GnRH treatments are reviewed in relation to prevention of embryo mortality, control of follicle development in synchronization programmes using PG as luteolysin, induction of ovulation in post-partum anoestrus and in bovine cystic ovarian disease. "
10/01/1999 - "The results question the efficacy of treating cystic ovarian disease with GnRH."
01/01/1991 - "The purpose of this study was to re-evaluate the quantitative and qualitative responses of LH to exogenous and endogenous GnRH stimulation in normally cycling women and in polycystic ovarian disease (PCOD). "
12/01/1987 - "This study shows that LH-RH agonist administration can selectively inhibit ovarian function and could be an interesting approach to evaluate the respective contribution of the ovary and adrenal on the pathophysiology of the polycystic ovarian disease. "

05/01/1980 - "hMG-hCG is an additional safe and effective, nonsurgical treatment for women with polycystic ovarian disease who have failed to respond to clomiphene therapy. "
04/01/2014 - "To evaluate the role of different clinical, biochemical and sonographic factors as predictors of spontaneous ovulation after laparoscopic ovarian drilling (LOD) in women with clomiphene citrate resistant polycystic ovarian disease (CCR-PCOD). "
04/01/2014 - "Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling."
02/01/2012 - "The indications for THL were: inconclusive hysterosalpingogram findings and ovarian drilling for clomiphene-resistant polycystic ovarian disease. "
09/01/1995 - "Ovulation problems can be treated with a high degree of success, except in cases of clomiphene resistant polycystic ovarian disease. "

02/13/1988 - "Retrospective analysis of the efficacy of different hormone treatments of cystic ovarian disease in cattle."
03/01/1993 - "This study was designed to investigate the basic concentrations of different hormones in obese and non-obese patients with polycystic ovarian disease (PCOD). "
01/01/2013 - "A number of laboratories are now measuring this hormone as part of IVF treatment and in the investigation of polycystic ovarian disease in particular. "
12/01/2000 - "Hypersecretion of luteinising hormone or ultrasonographic features of polycystic ovarian disease was present in 8% and 7.8% of women, respectively. "
07/01/1992 - "Aspiration of persistent follicles is a simple treatment for cystic ovarian disease that is nonresponsive to parenterally administered hormones. "

10/01/2008 - "Efficacy of intravaginal progesterone administration combined with prostaglandin f(2alpha) for cystic ovarian disease in Japanese Black cows."
08/01/2006 - "The objective of this study was to compare the economic benefits of timed artificial insemination (AI) and a progesterone insert as therapeutic treatments for cows diagnosed with cystic ovarian disease (COD). "
04/01/2011 - "Comparison of plasma concentrations of estradiol-17β and progesterone, and conception in dairy cows with cystic ovarian diseases between Ovsynch and Ovsynch plus CIDR timed AI protocols."
09/23/2000 - "Comparison of different methods of diagnosis of cystic ovarian disease in cattle and an assessment of its treatment with a progesterone-releasing intravaginal device."
12/01/1979 - "[Cystic ovarian disease in cattle: II. Clinical observations and plasma progesterone concentrations]."

08/01/1983 - "The combination of hMG-hCG and dexamethasone is an additional, safe, and effective nonsurgical treatment for women with polycystic ovarian disease who have failed to respond to an hMG-hCG regimen alone."
10/01/1982 - "Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease."
05/01/1977 - "A study was undertaken to assess the relative frequency of polycystic ovarian disease (POD) among patients with menstrual irregularities and/or hirsutism, and was based on 24-hour urinary steroid profiles under basal conditions, after dexamethasone suppression and after human chorionic gonadotrophin (HCG) stimulation. "
05/01/1999 - "Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease."
08/01/1983 - "Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease."

08/01/1993 - "Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog."
02/01/1977 - "The results are presented of treatment with cyproterone acetate of idiopathic hirsutism or hirsutism associated with polycystic ovarian disease. "
01/01/1987 - "Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease."
10/01/1986 - "Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease."
10/01/1986 - "A randomized cross-over study was done to compare the therapeutic efficacy of cyproterone acetate (CPA) and a depot preparation of the LHRH superagonist (DTrp6-LHRH) in 10 patients with polycystic ovarian disease (PCO). "

10/01/2008 - "The objective of this study was to investigate cystic ovarian disease (COD) in commercial Japanese Black cows and to evaluate the efficacy of 7-day insertion of an intravaginal progesterone insert (CIDR) combined with prostaglandin F(2alpha) (PGF(2alpha)) at CIDR removal. "

02/20/1990 - "[Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease]."
01/01/1989 - "Bromocriptine may have a place in the treatment of polycystic ovarian diseases with normoprolactinemia though its mechanism of action is unclear."
01/01/1989 - "Ten patients with polycystic ovarian disease and normoprolactinemia received bromocriptine 5 mg daily for up to 4 months. "
03/01/1988 - "Two out of nine amenorrheic polycystic ovarian disease patients menstruated during bromocriptine treatment, and three patients showed evidence of ovulation."
03/01/1988 - "Bromocriptine and placebo were given to a group of 20 polycystic ovarian disease patients on a double-blind, cross-over basis. "

03/01/2015 - "The aim of this review is to critically analyze, the safety and efficacy data of metformin regarding its use in GDM and pregnant mothers with polycystic ovarian disease, which has emerged in past decades. "
01/01/2011 - "A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder."
10/01/2001 - "To evaluate the clinical features, endocrine and metabolic profiles in clomiphene (CC) responders and non-responders with polycystic ovarian disease (PCOD), and to examine the effects of metformin (MTF) on the above parameters of CC resistance. "
10/01/2001 - "Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin."
06/01/2006 - "Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease."

10/01/1987 - "A longitudinal study was conducted to determine the effect of combined desogestrel-ethinylestradiol treatment on lipid profiles in 28 women with polycystic ovarian disease. "
10/01/1987 - "Effects of combined desogestrel-ethinylestradiol treatment on lipid profiles in women with polycystic ovarian disease."
07/01/1987 - " Although the effect of this treatment is temporary, the ethinyl estradiol-desogestrel OC appears to be effective in hyperandrogenic adolescents and may delay the progression of hirsutism and prevent adult micropolycystic ovarian disease."
12/01/1987 - "A longitudinal study to determine the effects of combined ethinylestradiol (EE) and desogestrel (DG) on hormone profiles and levels of sex hormone binding globulin (SHBG) were carried out in 19 Thai women with polycystic ovarian disease (PCOD). "
12/01/1987 - "Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease."

01/01/1990 - "The feasibility and efficacy of laparoscopic CO2 laser and Nd:YAG non-contact laser application for the treatment of polycystic ovarian disease (PCOD) were evaluated in 30 patients (19 patients treated with the CO2 laser, and 11 with the Nd:YAG laser). "
06/01/1994 - "Forty-four anovulatory women with polycystic ovarian disease (PCOD) were laparoscopically treated with the argon laser. "
06/01/1994 - "Polycystic ovarian disease treated by laparoscopic argon laser capsule drilling: comparison of vaporization versus perforation technique."
06/01/2001 - "Laparoscopic ovarian drilling using diathermy or laser is effective during the induction of ovulation and increases the pregnancy rate in cases of polycystic ovarian disease resistant to clomiphene citrate."
03/01/1998 - "Women who conceived following the surgery had a shorter duration of infertility, were treated with diathermy (rather than laser), had higher pre-operative luteinising hormone levels, were younger and were more likely to have ultrasonographic evidence of polycystic ovarian disease. "

09/01/1992 - "Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease."
01/01/1990 - "The feasibility and efficacy of laparoscopic CO2 laser and Nd:YAG non-contact laser application for the treatment of polycystic ovarian disease (PCOD) were evaluated in 30 patients (19 patients treated with the CO2 laser, and 11 with the Nd:YAG laser). "
02/01/1997 - "In a prospective study, 30 women with polycystic ovarian disease resistant to clomiphene citrate therapy and gonadotropins were treated success fully with laparoscopic ovarian CO2 laser vaporization or CO2 laser wedge resection."

03/01/2000 - "Bilateral or unilateral KTP laser ovarian drilling in polycystic ovarian disease."
01/01/1990 - "The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser."
01/01/1990 - "The feasibility and efficacy of laparoscopic CO2 laser and Nd:YAG non-contact laser application for the treatment of polycystic ovarian disease (PCOD) were evaluated in 30 patients (19 patients treated with the CO2 laser, and 11 with the Nd:YAG laser). "

07/24/2006 - "Recent genetic studies identified structural polymorphisms in Stfa1 and Stfa2 as candidates for Aod1b, a locus controlling susceptibility to day three thymectomy (D3Tx)-induced autoimmune ovarian disease (AOD). "
08/01/2001 - "Recent studies on autoimmune ovarian disease (AOD) induced by thymectomy on d3 (d3tx), and AOD induced by immunization with the ovary-specific zona pellucida 3 peptide (pZP3), have yielded the following results. "
04/01/2001 - "Female (C57BL/6xA/J)F(1) mice undergoing thymectomy on day 3 after birth (d3tx) developed autoimmune ovarian disease (AOD) and autoimmune disease of the lacrimal gland. "
01/01/2010 - "Here we asked whether the postnatal maternal environment could influence autoimmune disease development to day 3 thymectomy (d3tx)-induced autoimmune ovarian disease (AOD) and experimental allergic encephalomyelitis (EAE) in cross-fostered A/J and B6 mice. "
04/01/2001 - "Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy."

09/01/1995 - "In a multicenter randomized study, 55 patients with bilateral ovarian disease were treated at initial laparotomy. "
02/01/2004 - "Laparoscopic adnexectomy for benign tubo-ovarian disease using abdominal wall lift: a comparison to laparotomy."
10/01/2003 - "During a 2 year period (August 2000 to August 2002) 16 patients with polycystic ovarian disease were managed by minilaparotomy and ovarian drilling by diathermy. "
05/01/1995 - "Cost-benefit analysis of laparoscopic versus laparotomy salpingo-oophorectomy for benign tubo-ovarian disease."
10/01/1998 - "Operative laparoscopy has replaced the conventional approach by laparotomy to the treatment of most benign gynecological diseases (benign adnexal cysts, ectopic pregnancy, tubal infertility, polycystic ovarian disease, endometriosis, myomas), with advantages in terms of shorter hospital stay, less discomfort and complications for the patient, minor social costs due to the early resumption of normal working activities, and comparable results in terms of reproductive outcome."